Literature DB >> 9003747

Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.

H Tamizifar1, R Jennings, S A Ali, C W Potter.   

Abstract

Splenocytes from mice immunised with two doses of subunit influenza A/Beijing/353/89 vaccine mixed with whole cell DTP (wDTP), acellular DTP (aDTP) or PBS were collected 7 and 10 days after the second immunisation, and re-stimulated with subunit influenza vaccine or live virus in vitro. Interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) were assayed in supernates from these cultures by an ELISA procedure. Splenocytes from mice given subunit influenza vaccine in wDTP produced greater than two-fold and greater than five-fold responses of IL-2 and IFN-gamma, respectively, compared with splenocytes from mice immunised with subunit vaccine alone. In contrast, the response of splenocytes from mice immunised with subunit vaccine in saline or aDTP was similar, significantly less than for vaccine in wDTP (p < 0.01) and only slightly greater than for controls (p < 0.05). The production of IL-2 and IFN-gamma by these spleen cells was not significantly different on days 7 and 10 post-immunisation. Previous reports have shown that wDTP and aDTP enhance the serum antibody response of mice to influenza vaccine, but wDTP enhanced the response 100-fold greater than aDTP, and induced greater IgG2a and IgG2b subclass antibody responses; this last result indicates a cell-mediated immune response to vaccine. The present studies confirm these earlier findings; furthermore, as the IL-2 and IFN-gamma responses of splenocytes are associated with Th-1 subset T-lymphocyte response, the findings indicate a cytotoxic T-cell response to immunisation. The results indicate that influenza vaccine combined with wDTP induced a cell-mediated response in mice, which could confer a more solid immunity to challenge virus infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003747     DOI: 10.1099/00222615-46-1-61

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Evaluation of traditional medicines III: the mechanism of immune modulation by PHELA.

Authors:  Makhotso Lekhooa; Andrew Walubo; Jan J B Du Plessis; Motlalepula G Matsabisa
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-02-13

2.  Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.

Authors:  Fernanda A Lima; Daniela M Ferreira; Adriana T Moreno; Patrícia C D Ferreira; Giovana M P Palma; Jorge M C Ferreira; Isaias Raw; Eliane N Miyaji; Paulo L Ho; Maria Leonor S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

3.  Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.

Authors:  M Pasetti; P Eriksson; F Ferrero; M Manghi
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

4.  Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.

Authors:  Carolina Salcedo-Rivillas; Anne-Sophie Debrie; Eliane Namie Miyaji; Jorge M C Ferreira; Isaías Raw; Camille Locht; Paulo L Ho; Nathalie Mielcarek; Maria Leonor S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

5.  Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Authors:  Maria Leonor S Oliveira; Eliane N Miyaji; Daniela M Ferreira; Adriana T Moreno; Patricia C D Ferreira; Fernanda A Lima; Fernanda L Santos; Maria Aparecida Sakauchi; Célia S Takata; Hisako G Higashi; Isaías Raw; Flavia S Kubrusly; Paulo L Ho
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.